Gyre Therapeutics, Inc. (GYRE) Revenue 2013–2025
Gyre Therapeutics, Inc. (GYRE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$116.6MFY2025 · since FY2013: $3.6M → $116.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $116.6M | +10.2% |
| FY2024 | $105.8M | -6.8% |
| FY2023 | $113.5M | +10.9% |
| FY2022 | $102.3M | +1294.0% |
| FY2021 | $7.3M | -65.0% |
| FY2020 | $20.9M | — |
| FY2018 | $6,000 | -99.4% |
| FY2017 | $1.0M | — |
| FY2014 | $275,000 | -92.4% |
| FY2013 | $3.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice